APO Research
Talk to an analyst

APO RESEARCH · REPORT

Preterm Birth Prevention and Management

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Preterm Birth Prevention and Management Market Outlook and Growth Opportunities 2026

2 January 2026192 pages

Choose your research edition.

Industry ResearchPreterm Birth Prevention and Management Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Preterm Birth Prevention and Management Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Preterm Birth Prevention and Management Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Preterm Birth Prevention and Management Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Preterm Birth Prevention and Management Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Preterm Birth Prevention and Management market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Preterm Birth Prevention and Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Preterm Birth Prevention and Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Preterm Birth Prevention and Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Preterm Birth Prevention and Management market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Preterm Birth Prevention and Management market include Teva, Sanofi, Novartis, Pfizer, Bayer, AbbVie, Viatris, Merck & Co and Ferring Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Preterm Birth Prevention and Management market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Preterm Birth Prevention and Management and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Preterm Birth Prevention and Management revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Preterm Birth Prevention and Management market.

Preterm Birth Prevention and Management Segment by Company

Teva

Sanofi

Novartis

Pfizer

Bayer

AbbVie

Viatris

Merck & Co

Ferring Pharmaceutical

Aurobindo Pharma

AMAG Pharmaceuticals

Allergan

Preterm Birth Prevention and Management Segment by Type

Antihypertensive Therapy

Magnesium Sulfate Therapy

Corticosteroid Therapy

Tocolytics Therapy

Progesterone Therapy

Other

Preterm Birth Prevention and Management Segment by Application

Hospital

Drugs Stores

Other

Preterm Birth Prevention and Management Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Preterm Birth Prevention and Management status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Preterm Birth Prevention and Management key companies, revenue, market share, and recent developments.

3. To split the Preterm Birth Prevention and Management breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Preterm Birth Prevention and Management market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Preterm Birth Prevention and Management significant trends, drivers, influence factors in global and regions.

6. To analyze Preterm Birth Prevention and Management competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Preterm Birth Prevention and Management market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Preterm Birth Prevention and Management and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Preterm Birth Prevention and Management.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Preterm Birth Prevention and Management industry.

Chapter 3: Detailed analysis of Preterm Birth Prevention and Management company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Preterm Birth Prevention and Management in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Preterm Birth Prevention and Management in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Preterm Birth Prevention and Management Industry Trends Table 2. Preterm Birth Prevention and Management Industry Drivers Table 3. Preterm Birth Prevention and Management Industry Opportunities and Challenges Table 4. Preterm Birth Prevention and Management Industry Restraints Table 5. Global Preterm Birth Prevention and Management Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Preterm Birth Prevention and Management Revenue Share by Company (2021-2026) Table 7. Global Preterm Birth Prevention and Management Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Preterm Birth Prevention and Management Key Company Manufacturing Base & Headquarters Table 9. Global Preterm Birth Prevention and Management Company, Product Type & Application Table 10. Global Preterm Birth Prevention and Management Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Preterm Birth Prevention and Management by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Antihypertensive Therapy Table 15. Significant Companies of Magnesium Sulfate Therapy Table 16. Significant Companies of Corticosteroid Therapy Table 17. Significant Companies of Tocolytics Therapy Table 18. Significant Companies of Progesterone Therapy Table 19. Significant Companies of Other Table 20. Global Preterm Birth Prevention and Management Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 21. Global Preterm Birth Prevention and Management Sales Value by Type (2021-2026) & (US$ Million) Table 22. Global Preterm Birth Prevention and Management Sales Value by Type (2027-2032) & (US$ Million) Table 23. Global Preterm Birth Prevention and Management Sales Value Share by Type (2021-2026) Table 24. Global Preterm Birth Prevention and Management Sales Value Share by Type (2027-2032) Table 25. Significant Companies of Hospital Table 26. Significant Companies of Drugs Stores Table 27. Significant Companies of Other Table 28. Global Preterm Birth Prevention and Management Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Preterm Birth Prevention and Management Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global Preterm Birth Prevention and Management Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global Preterm Birth Prevention and Management Sales Value Share by Application (2021-2026) Table 32. Global Preterm Birth Prevention and Management Sales Value Share by Application (2027-2032) Table 33. Global Preterm Birth Prevention and Management Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Preterm Birth Prevention and Management Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global Preterm Birth Prevention and Management Sales Value Share by Region (2021-2026) Table 36. Global Preterm Birth Prevention and Management Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global Preterm Birth Prevention and Management Sales Value Share by Region (2027-2032) Table 38. Global Preterm Birth Prevention and Management Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Preterm Birth Prevention and Management Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global Preterm Birth Prevention and Management Sales Value Market Share by Country (2021-2026) Table 41. Global Preterm Birth Prevention and Management Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global Preterm Birth Prevention and Management Sales Value Market Share by Country (2027-2032) Table 43. Teva Company Information Table 44. Teva Business Overview Table 45. Teva Preterm Birth Prevention and Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Teva Preterm Birth Prevention and Management Product Portfolio Table 47. Teva Recent Development Table 48. Sanofi Company Information Table 49. Sanofi Business Overview Table 50. Sanofi Preterm Birth Prevention and Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Sanofi Preterm Birth Prevention and Management Product Portfolio Table 52. Sanofi Recent Development Table 53. Novartis Company Information Table 54. Novartis Business Overview Table 55. Novartis Preterm Birth Prevention and Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Novartis Preterm Birth Prevention and Management Product Portfolio Table 57. Novartis Recent Development Table 58. Pfizer Company Information Table 59. Pfizer Business Overview Table 60. Pfizer Preterm Birth Prevention and Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Pfizer Preterm Birth Prevention and Management Product Portfolio Table 62. Pfizer Recent Development Table 63. Bayer Company Information Table 64. Bayer Business Overview Table 65. Bayer Preterm Birth Prevention and Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Bayer Preterm Birth Prevention and Management Product Portfolio Table 67. Bayer Recent Development Table 68. AbbVie Company Information Table 69. AbbVie Business Overview Table 70. AbbVie Preterm Birth Prevention and Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. AbbVie Preterm Birth Prevention and Management Product Portfolio Table 72. AbbVie Recent Development Table 73. Viatris Company Information Table 74. Viatris Business Overview Table 75. Viatris Preterm Birth Prevention and Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Viatris Preterm Birth Prevention and Management Product Portfolio Table 77. Viatris Recent Development Table 78. Merck & Co Company Information Table 79. Merck & Co Business Overview Table 80. Merck & Co Preterm Birth Prevention and Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Merck & Co Preterm Birth Prevention and Management Product Portfolio Table 82. Merck & Co Recent Development Table 83. Ferring Pharmaceutical Company Information Table 84. Ferring Pharmaceutical Business Overview Table 85. Ferring Pharmaceutical Preterm Birth Prevention and Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Ferring Pharmaceutical Preterm Birth Prevention and Management Product Portfolio Table 87. Ferring Pharmaceutical Recent Development Table 88. Aurobindo Pharma Company Information Table 89. Aurobindo Pharma Business Overview Table 90. Aurobindo Pharma Preterm Birth Prevention and Management Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Aurobindo Pharma Preterm Birth Prevention and Management Product Portfolio Table 92. Aurobindo Pharma Recent Development Table 93. AMAG Pharmaceuticals Company Information Table 94. AMAG Pharmaceuticals Business Overview Table 95. AMAG Pharmaceuticals Preterm Birth Prevention and Management Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. AMAG Pharmaceuticals Preterm Birth Prevention and Management Product Portfolio Table 97. AMAG Pharmaceuticals Recent Development Table 98. Allergan Company Information Table 99. Allergan Business Overview Table 100. Allergan Preterm Birth Prevention and Management Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Allergan Preterm Birth Prevention and Management Product Portfolio Table 102. Allergan Recent Development Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources Table 106. Primary Sources List of Figures Figure 1. Preterm Birth Prevention and Management Product Image Figure 2. Global Preterm Birth Prevention and Management Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Preterm Birth Prevention and Management Market Size (2021-2032) & (US$ Million) Figure 4. Global Preterm Birth Prevention and Management Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Antihypertensive Therapy Image Figure 8. Magnesium Sulfate Therapy Image Figure 9. Corticosteroid Therapy Image Figure 10. Tocolytics Therapy Image Figure 11. Progesterone Therapy Image Figure 12. Other Image Figure 13. Global Preterm Birth Prevention and Management Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 14. Global Preterm Birth Prevention and Management Sales Value Share 2021 VS 2025 VS 2032 Figure 15. Global Preterm Birth Prevention and Management Sales Value Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Drugs Stores Image Figure 18. Other Image Figure 19. Global Preterm Birth Prevention and Management Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Preterm Birth Prevention and Management Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Preterm Birth Prevention and Management Sales Value Share by Application (2021-2032) Figure 22. Global Preterm Birth Prevention and Management Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Preterm Birth Prevention and Management Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America Preterm Birth Prevention and Management Sales Value (2021-2032) & (US$ Million) Figure 25. North America Preterm Birth Prevention and Management Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe Preterm Birth Prevention and Management Sales Value (2021-2032) & (US$ Million) Figure 27. Europe Preterm Birth Prevention and Management Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific Preterm Birth Prevention and Management Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific Preterm Birth Prevention and Management Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America Preterm Birth Prevention and Management Sales Value (2021-2032) & (US$ Million) Figure 31. South America Preterm Birth Prevention and Management Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa Preterm Birth Prevention and Management Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Preterm Birth Prevention and Management Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • Antihypertensive Therapy
  • Magnesium Sulfate Therapy
  • Corticosteroid Therapy
  • Tocolytics Therapy
  • Progesterone Therapy
  • Other
Applications
  • Hospital
  • Drugs Stores
  • Other
Companies covered
  • Teva
  • Sanofi
  • Novartis
  • Pfizer
  • Bayer
  • AbbVie
  • Viatris
  • Merck & Co
  • Ferring Pharmaceutical
  • Aurobindo Pharma
  • AMAG Pharmaceuticals
  • Allergan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Preterm Birth Prevention and Management Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Preterm Birth Prevention and Management Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Preterm Birth Prevention and Management Market Dynamics
  1. 2.1 Preterm Birth Prevention and Management Industry Trends
  2. 2.2 Preterm Birth Prevention and Management Industry Drivers
  3. 2.3 Preterm Birth Prevention and Management Industry Opportunities and Challenges
  4. 2.4 Preterm Birth Prevention and Management Industry Restraints
3 Preterm Birth Prevention and Management Market by Company
  1. 3.1 Global Preterm Birth Prevention and Management Company Revenue Ranking in 2025
  2. 3.2 Global Preterm Birth Prevention and Management Revenue by Company (2021-2026)
  3. 3.3 Global Preterm Birth Prevention and Management Company Ranking (2024-2026)
  4. 3.4 Global Preterm Birth Prevention and Management Company Manufacturing Base and Headquarters
  5. 3.5 Global Preterm Birth Prevention and Management Company Product Type and Application
  6. 3.6 Global Preterm Birth Prevention and Management Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Preterm Birth Prevention and Management Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Preterm Birth Prevention and Management Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Preterm Birth Prevention and Management Market by Type
  1. 4.1 Preterm Birth Prevention and Management Type Introduction
  2. 4.1.1 Antihypertensive Therapy
  3. 4.1.2 Magnesium Sulfate Therapy
  4. 4.1.3 Corticosteroid Therapy
  5. 4.1.4 Tocolytics Therapy
  6. 4.1.5 Progesterone Therapy
  7. 4.1.6 Other
  8. 4.2 Global Preterm Birth Prevention and Management Sales Value by Type
  9. 4.2.1 Global Preterm Birth Prevention and Management Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Preterm Birth Prevention and Management Sales Value by Type (2021-2032)
  11. 4.2.3 Global Preterm Birth Prevention and Management Sales Value Share by Type (2021-2032)
5 Preterm Birth Prevention and Management Market by Application
  1. 5.1 Preterm Birth Prevention and Management Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Drugs Stores
  4. 5.1.3 Other
  5. 5.2 Global Preterm Birth Prevention and Management Sales Value by Application
  6. 5.2.1 Global Preterm Birth Prevention and Management Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Preterm Birth Prevention and Management Sales Value by Application (2021-2032)
  8. 5.2.3 Global Preterm Birth Prevention and Management Sales Value Share by Application (2021-2032)
6 Preterm Birth Prevention and Management Regional Value Analysis
  1. 6.1 Global Preterm Birth Prevention and Management Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Preterm Birth Prevention and Management Sales Value by Region (2021-2032)
  3. 6.2.1 Global Preterm Birth Prevention and Management Sales Value by Region: 2021-2026
  4. 6.2.2 Global Preterm Birth Prevention and Management Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Preterm Birth Prevention and Management Sales Value (2021-2032)
  7. 6.3.2 North America Preterm Birth Prevention and Management Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Preterm Birth Prevention and Management Sales Value (2021-2032)
  10. 6.4.2 Europe Preterm Birth Prevention and Management Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Preterm Birth Prevention and Management Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Preterm Birth Prevention and Management Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Preterm Birth Prevention and Management Sales Value (2021-2032)
  16. 6.6.2 South America Preterm Birth Prevention and Management Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Preterm Birth Prevention and Management Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Preterm Birth Prevention and Management Sales Value Share by Country, 2025 VS 2032
7 Preterm Birth Prevention and Management Country-level Value Analysis
  1. 7.1 Global Preterm Birth Prevention and Management Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Preterm Birth Prevention and Management Sales Value by Country (2021-2032)
  3. 7.2.1 Global Preterm Birth Prevention and Management Sales Value by Country (2021-2026)
  4. 7.2.2 Global Preterm Birth Prevention and Management Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Preterm Birth Prevention and Management Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Preterm Birth Prevention and Management Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Preterm Birth Prevention and Management Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Preterm Birth Prevention and Management Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Preterm Birth Prevention and Management Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi Preterm Birth Prevention and Management Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Preterm Birth Prevention and Management Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 Novartis
  14. 8.3.1 Novartis Company Information
  15. 8.3.2 Novartis Business Overview
  16. 8.3.3 Novartis Preterm Birth Prevention and Management Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Novartis Preterm Birth Prevention and Management Product Portfolio
  18. 8.3.5 Novartis Recent Developments
  19. 8.4 Pfizer
  20. 8.4.1 Pfizer Company Information
  21. 8.4.2 Pfizer Business Overview
  22. 8.4.3 Pfizer Preterm Birth Prevention and Management Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Preterm Birth Prevention and Management Product Portfolio
  24. 8.4.5 Pfizer Recent Developments
  25. 8.5 Bayer
  26. 8.5.1 Bayer Company Information
  27. 8.5.2 Bayer Business Overview
  28. 8.5.3 Bayer Preterm Birth Prevention and Management Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Bayer Preterm Birth Prevention and Management Product Portfolio
  30. 8.5.5 Bayer Recent Developments
  31. 8.6 AbbVie
  32. 8.6.1 AbbVie Company Information
  33. 8.6.2 AbbVie Business Overview
  34. 8.6.3 AbbVie Preterm Birth Prevention and Management Revenue and Gross Margin (2021-2026)
  35. 8.6.4 AbbVie Preterm Birth Prevention and Management Product Portfolio
  36. 8.6.5 AbbVie Recent Developments
  37. 8.7 Viatris
  38. 8.7.1 Viatris Company Information
  39. 8.7.2 Viatris Business Overview
  40. 8.7.3 Viatris Preterm Birth Prevention and Management Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Viatris Preterm Birth Prevention and Management Product Portfolio
  42. 8.7.5 Viatris Recent Developments
  43. 8.8 Merck & Co
  44. 8.8.1 Merck & Co Company Information
  45. 8.8.2 Merck & Co Business Overview
  46. 8.8.3 Merck & Co Preterm Birth Prevention and Management Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Merck & Co Preterm Birth Prevention and Management Product Portfolio
  48. 8.8.5 Merck & Co Recent Developments
  49. 8.9 Ferring Pharmaceutical
  50. 8.9.1 Ferring Pharmaceutical Company Information
  51. 8.9.2 Ferring Pharmaceutical Business Overview
  52. 8.9.3 Ferring Pharmaceutical Preterm Birth Prevention and Management Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Ferring Pharmaceutical Preterm Birth Prevention and Management Product Portfolio
  54. 8.9.5 Ferring Pharmaceutical Recent Developments
  55. 8.10 Aurobindo Pharma
  56. 8.10.1 Aurobindo Pharma Company Information
  57. 8.10.2 Aurobindo Pharma Business Overview
  58. 8.10.3 Aurobindo Pharma Preterm Birth Prevention and Management Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Aurobindo Pharma Preterm Birth Prevention and Management Product Portfolio
  60. 8.10.5 Aurobindo Pharma Recent Developments
  61. 8.11 AMAG Pharmaceuticals
  62. 8.11.1 AMAG Pharmaceuticals Company Information
  63. 8.11.2 AMAG Pharmaceuticals Business Overview
  64. 8.11.3 AMAG Pharmaceuticals Preterm Birth Prevention and Management Revenue and Gross Margin (2021-2026)
  65. 8.11.4 AMAG Pharmaceuticals Preterm Birth Prevention and Management Product Portfolio
  66. 8.11.5 AMAG Pharmaceuticals Recent Developments
  67. 8.12 Allergan
  68. 8.12.1 Allergan Company Information
  69. 8.12.2 Allergan Business Overview
  70. 8.12.3 Allergan Preterm Birth Prevention and Management Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Allergan Preterm Birth Prevention and Management Product Portfolio
  72. 8.12.5 Allergan Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst